Trials / Terminated
TerminatedNCT00625833
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
A Randomized, Double-Blind Placebo Controlled Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a trial to investigate the effectiveness and safety of \[S,S\]-Reboxetine in relieving chronic peripheral pain suffered by patients with diabetes. Some evidence for the effectiveness of \[S,S\]- Reboxetine in relieving chronic pain has been seen in 3 completed trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Oral tablet once a day dosing for 10 weeks. |
| DRUG | [S,S]-Reboxetine | Oral tablet once a day dosing for 10 weeks. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2008-02-28
- Last updated
- 2019-12-13
Locations
56 sites across 6 countries: United States, Czechia, Finland, Netherlands, South Africa, Spain
Source: ClinicalTrials.gov record NCT00625833. Inclusion in this directory is not an endorsement.